Instituto de Biología y Medicina Experimental (IBYME)

What Instituto de Biología y Medicina Experimental (IBYME) does

Instituto de Biología y Medicina Experimental (IBYME) is a non-profit biomedical research institute founded in 1944 by Nobel laureate Dr. Bernardo Houssay in Buenos Aires, Argentina, operating under a dual-dependence governance structure between CONICET (Argentina's national scientific and technical research council) and Fundación IBYME. The institute conducts basic and applied research across six areas — Cellular and Molecular Biology, Endocrinology, Immunology, Neurosciences and Behavior, Oncology, and Reproduction — supported by more than 30 specialized laboratories, an indexed publication archive of 85+ pages, and complementary facilities including a library, animal facility (Bioterio), and dedicated microscopy and flow cytometry services. Its commercialization arm is the STAN IBYME-CONICET platform (Servicios Tecnológicos de Alto Nivel), a portfolio of more than 50 high-level technological services including glycomics analysis via HPLC/UPLC-HILIC, ZEISS LSM 880 confocal microscopy with Airyscan, laser capture microdissection, flow cytometry, single-cell gene expression, isothermal titration calorimetry, in vitro and in vivo drug testing for cancer and Alzheimer's, IVF and embryo transfer, histology, and hormone radioimmunoassay. The institute also hosts technology-based spin-offs such as Fecundis, which commercializes HyperSperm sperm capacitation technology for assisted reproduction.

Revenue is generated through four streams: (1) government funding from CONICET for research positions and operations, (2) STAN service fees charged to external clients (companies, educational institutions, healthcare organizations, and other research entities) under quote-based pricing regulated by CONICET resolutions, (3) donations and grants through Fundación IBYME (including from Fundación René Barón and Fundación Williams), and (4) revenue from postgraduate courses, seminars, and training programs. Customer segments are diverse: internal scientific research community, external research organizations, graduate students, and pharmaceutical/biotechnology companies seeking preclinical services. Regulatory independence is enforced through an accredited Ethics Committee (CCE, since 2013, renewed 2025), RENIS registration for health research, and CICUAL oversight for animal research.

Name

Instituto de Biología y Medicina Experimental (IBYME)

Legal name

Instituto de Biología y Medicina Experimental

Website

https://ibyme.org.ar

Company type

Private

Founded year

1944

Operating status

Operating

Headcount range

51–100 employees

Short description

IBYME is a Buenos Aires-based non-profit biomedical research institute founded in 1944, operating under CONICET and Fundación IBYME. It conducts basic and applied research across six areas and commercializes 50+ high-level technological services (STAN) plus spin-offs like Fecundis.

Ownership category

akta.pro rank

Product category

Biomedical Research Services

NAICS

Research and Development in Biotechnology (except Nanobiotechnology) (541714), Scientific Research and Development Services (5417), Medical Laboratories (621511)

SIC

Services-Commercial Physical & Biological Research (8731), Services-Testing Laboratories (8734), Services-Medical Laboratories (8071)

akta.pro primary industry

Clinical Research & Trial Central Laboratories (HLAFAMAL)

Keywords

• Biomedical research services
• Endocrinology research
• Immunology research
• Technology service platforms
• Preclinical research

Headquarters

HQ city

Buenos Aires

HQ country

Argentina

HQ region

Latin America

Offices1 record

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Technology or R&D, Infrastructure, Operations

Revenue model

1. Public Funding (CONICET): As a CONICET research unit, IBYME receives government funding for scientific research, investigator positions, and operational costs through the Argentine National Scientific and Technical Research Council.
2. Technological Services (STAN): IBYME provides over 50 high-level technological services to external clients including companies, educational institutions, healthcare providers, and research organizations. Services range from glycomics analysis, flow cytometry, microscopy, animal testing, consulting, and specialized research assistance.
3. Foundation Support: Fundación IBYME supports the institute's operations through donations and grants, including equipment acquisition funding from private foundations such as Fundación René Barón and Fundación Williams.
4. Educational Programs: The institute generates revenue through postgraduate courses, seminars, and training programs at undergraduate and graduate levels.

Go-to-market motion2 records

Distribution channels1 record

Marketing channels7 records

Core offering

IBYME is a non-profit biomedical research institute that conducts basic and applied scientific research across six core areas — cellular and molecular biology, endocrinology, immunology, neurosciences and behavior, oncology, and reproduction — operating more than 30 laboratories staffed by 88 employees. It commercializes its research infrastructure through the STAN platform, which offers 50+ specialized technological services to external research, pharmaceutical, and clinical clients, and develops proprietary translational products such as the HyperSperm sperm-selection device and the BIMOVA ovulation-prediction platform. Revenue is generated through STAN service fees, public research grants (CONICET), foundation donations, and tuition from postgraduate academic programs.

Product overview

IBYME operates as a dual-dependence research institute (CONICET – Fundación IBYME) established in 1944 under Nobel laureate Dr. Bernardo Houssay, conducting basic and applied research across six areas: Cellular and Molecular Biology, Endocrinology, Immunology, Neurosciences and Behavior, Oncology, and Reproduction. Its technology transfer arm is the STAN IBYME-CONICET (Servicios Tecnológicos de Alto Nivel) portfolio, a collection of 50+ high-level scientific services covering glycomics and structural analysis (glycosylation, monosaccharide, sialic acid speciation), cryopreservation, flow cytometry, confocal and laser capture microdissection microscopy, in vitro and in vivo drug efficacy/toxicity testing for cancer and Alzheimer's disease, single-cell gene expression analysis, behavioral testing, IVF and embryo transfer, isothermal titration calorimetry, histology, and hormone radioimmunoassay. Infrastructure is supported by complementary facilities including the Bernardo A. Houssay Library, an Animal Facility (Bioterio), Microscopy Service, and Flow Cytometry Service. Research governance is ensured by an Ethics Committee (accredited since 2013, renewed 2025) and a CICUAL (Institutional Committee for the Care and Use of Laboratory Animals). The institute also hosts technology-based companies (EBTs) such as Fecundis, which commercializes the HyperSperm sperm capacitation enhancement technology.

Differentiator

Problem solved

Functional benefit

Products and services

• STAN Technological Services Platform An integrated service platform offering 50+ specialized technological services (including cell culture, advanced microscopy, flow cytometry, proteomics, molecular biology, behavioral phenotyping, biobanking, and access to SPF animal facilities) for external research, pharmaceutical, biotechnology, and clinical clients seeking fee-based access to advanced biomedical infrastructure.
• HyperSperm A proprietary device/technology for selecting sperm cells with intact DNA, derived from IBYME's Reproduction research area, intended for use in assisted reproductive technology (ART) and clinical fertility applications.
• BIMOVA A proprietary platform/technology for predicting menstrual cycle phase and ovulation timing, derived from IBYME's Reproduction research area, intended for clinical, reproductive-health, and fertility applications.
• Postgraduate Academic Programs (Doctorado, Maestría, Especialización) Accredited postgraduate academic programs (doctoral, master's, and specialization degrees) in biomedical sciences, anchored in IBYME's 30+ research laboratories and delivered under CONICET academic oversight, intended for graduate students and early-career researchers seeking advanced biomedical research training.
• Preclinical and Translational Research Services Preclinical and translational research services spanning IBYME's six research areas (cellular and molecular biology, endocrinology, immunology, neurosciences and behavior, oncology, and reproduction), delivered to academic, clinical, pharmaceutical, and biotechnology clients through the STAN platform and direct collaborations.

Quantifiable outcome

• HyperSperm technology showed improved number and quality of embryos in multicenter IVF study
• +1 more outcomes

Segments4 records

Ideal customer profiles3 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature6 records

Partnerships

Four partnerships are on record, tiered core and minor.

• FecundiscoreTechnology or Integration · 1 July 2026Fecundis is a technology-based company (EBT - Empresa de Base Tecnológica) developed from IBYME research. The company commercializes HyperSperm technology for assisted reproduction, developed by IBYME researchers including Dr. Mariano Buffone. The company operates within IBYME facilities.
• Mercosur Southern Agencies AllianceminorStrategic or Co-development Partner · 1 July 2026IBYME hosts a Brazilian delegation visit as part of an alliance between Southern Mercosur agencies, indicating regional scientific collaboration.
• CONICETcoreOthers · 1 January 1944IBYME operates as a dual-dependence research unit with CONICET (Consejo Nacional de Investigaciones Científicas y Técnicas), Argentina's national scientific and technical research council. CONICET provides funding, researcher positions, and administrative oversight through Resolution D. No 3596/09 and related regulations.
• Fundación IBYMEcoreStrategic or Co-development Partner · 1 January 1944Fundación IBYME is the founding partner that co-governs the institute alongside CONICET. The foundation supports IBYME's work since 1944, continuing the objectives established by founders Drs. Houssay, Braun Menéndez, and Foglia. Foundation provides equipment donations, course funding, and operational support.

Scale indicators6 records

Recent moves7 records

Expansion highlights5 records

Others

• WuXi AppTec: Global CRO/CDMO providing preclinical drug testing, biologics characterization, and genomics services. Comparable to IBYME's STAN portfolio (glycomics, in vitro proliferation assays, single-cell gene expression) in serving biopharma R&D workflows, though at global scale.

Broad incumbents

• IQVIA: Global clinical research and life sciences services provider spanning real-world data, lab services, and clinical trial support. Comparable to IBYME's role as a regulated laboratory services platform serving pharma/biotech clients, though operating as a large commercial incumbent.
• Charles River Laboratories: Global contract research organization offering preclinical drug efficacy and safety testing, including in vivo oncology and neuroscience models. Comparable to IBYME's STAN services for in vitro/in vivo antitumor and Alzheimer's drug testing (STAN codes 1010, 7666, 7667), though at vastly greater scale and as a commercial CRO rather than a public institute.
• Labcorp: Global clinical and diagnostic laboratory network with central laboratory capabilities supporting clinical trials and biomedical research. Comparable to IBYME's clinical laboratory functions such as the COVID-T T-cell response platform and SARS-CoV-2 neutralizing antibody assays (STAN 5718, 5604).

Regional players

• Instituto Pasteur de Montevideo: Uruguayan biomedical research institute affiliated with the global Pasteur Network, conducting research in immunology, infectious diseases, and structural biology. Comparable to IBYME as a Latin American regional biomedical research center with similar institutional structure and services portfolio.
• Fundação Oswaldo Cruz (Fiocruz): Brazilian public health and biomedical research institution operating under the Ministry of Health, with extensive labs, technology platforms, and graduate training programs. Comparable to IBYME as a large Latin American government-affiliated biomedical research and technology services organization.

Direct peers

• Instituto de Investigaciones en Ingeniería Genética y Biología Molecular (INGEBI): CONICET-affiliated Buenos Aires institute conducting research in molecular biology and genetics. Comparable to IBYME in governance structure (dual-dependence with CONICET), research scope, and role as a public-sector biomedical research hub in Argentina.
• Instituto Leloir: Buenos Aires-based biomedical research institute founded with CONICET support, focused on molecular biology, structural biology, and cell biology. Directly comparable to IBYME as a peer Argentine CONICET-dependent biomedical research center offering advanced technology platforms and graduate training.
• Instituto Pasteur de Buenos Aires: Buenos Aires-based research institute focused on microbiology, immunology, and infectious diseases, with historical Pasteur Institute affiliation. Directly comparable to IBYME as a peer Argentine biomedical research center with public-sector funding and a strong publication record.

Emerging players

• Fecundis: Technology-based company (EBT) incubated at IBYME that commercializes HyperSperm sperm capacitation technology for assisted reproduction. Comparable to IBYME as a spin-out emerging player leveraging IBYME's reproductive biology research infrastructure and demonstrating the institute's technology transfer model.

Market position

Strengths4 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

• YouTubeyoutube.com/ibymeconicet
• LinkedInlinkedin.com/company/ibyme

Compliance1 record

Revenue estimate

Valuation estimate

Number of profiles

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Instituto de Biología y Medicina Experimental (IBYME)